Jiebing Tang

发表论文 4 篇 · 总被引 38 次 · h-index 2

代表论文

• The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial (2025 · Nature Communications · 被引 35)
• RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis (2023 · Acta Biochimica et Biophysica Sinica · 被引 7)
• Cadonilimab in combination with ivonescimab and chemotherapy as first-line (1L) therapy in patients with advanced gastric (G) or gastroesophageal junction adenocarcinoma (GEJA). (2025 · Journal of Clinical Oncology · 被引 5)
• Electroacupuncture Combined with Fruquintinib and Sintilimab in Microsatellite-Stable Metastatic Colorectal Cancer: A Phase II Study. (2026 · Cancer Letters · 被引 2)